Name | bupivacaine hydrochloride hydrate |
---|---|
Synonyms |
Win 11,318
Bupivacaine HCl H2-O 1-butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide hydrate hydrochloride Bupivacaine hydrochloride Marcaine (TN) 1-butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide,hydrate,hydrochloride 2-Piperidinecarboxamide,1-butyl-N-(2,6-dimethylphenyl)-,monohydrochloride,monohydrate |
Description | Bupivacaine hydrochloride monohydrate is a NMDA receptor inhibitor. Bupivacaine hydrochloride monohydrate can block sodium, L-calcium, and potassium channels. Bupivacaine hydrochloride monohydrate potently blocks SCN5A channels with the IC50 of 69.5 μM. Bupivacaine hydrochloride monohydrate can be used for the research of chronic pain[1][2][3]. |
---|---|
Related Catalog | |
Target |
NMDA Receptor |
References |
Melting Point | 255-259℃ |
---|---|
Molecular Formula | C18H31ClN2O2 |
Molecular Weight | 342.90 |
Exact Mass | 342.20700 |
PSA | 45.06000 |
LogP | 5.22160 |
Symbol |
GHS06 |
---|---|
Signal Word | Danger |
Hazard Statements | H300 + H310 + H330 |
Precautionary Statements | P260-P264-P280-P284-P301 + P310-P302 + P350 |
Personal Protective Equipment | Eyeshields;Faceshields;full-face particle respirator type N100 (US);Gloves;respirator cartridge type N100 (US);type P1 (EN143) respirator filter;type P3 (EN 143) respirator cartridges |
Hazard Codes | T+ |
Risk Phrases | 26/27/28 |
Safety Phrases | 22-36/37/39-45 |
RIDADR | UN 2811 6.1 / PGII |
RTECS | TK6125000 |
Hazard Class | 6.1 |